820
L. Gavara et al. / Tetrahedron Letters 54 (2013) 817–820
3. Stowell, M. H. B.; Witte, J. F.; McClard, R. W. Tetrahedron Lett. 1989, 30, 411.
In conclusion, the phospha-Claisen condensation was investi-
4. For related work, see: (a) Schulback, M. C.; Mahapatra, S.; Macchia, M.;
Barontini, S.; Papi, C.; Minutolo, F.; Bertini, S.; Brennan, P. J.; Crick, D. C. J. Biol.
Chem. 2001, 276, 11624; (b) Prashad, M.; Tomesch, J. C.; Wareing, J. R.; Scallen,
T. Eur. J. Med. Chem. 1993, 28, 527.
5. Examples: (a) Smits, J. P.; Wiemer, D. F. J. Org. Chem. 2011, 76, 8807; (b) Gao, J.;
Chu, X.; Qiu, Y.; Wu, L.; Qiao, Y.; Wu, J.; Li, D. Chem. Commun. 2010, 46, 5340; (c)
Abrunhosa-Thomas, I.; Sellers, C. E.; Montchamp, J.-L. J. Org. Chem. 2007, 72,
2851; (d) Zakharova, S.; Fulhorst, M.; Luczak, L.; Wessjohann, L. ARKIVOC 2004,
79; (e) Klein, E.; Nghiêm, H.-O.; Valleix, A.; Mioskowski, C.; Lebeau, L. Chem.
Eur. J. 2002, 8, 4649; (f) Klein, E.; Mons, S.; Valleix, A.; Mioskowski, C.; Lebeau, L.
J. Org. Chem. 2002, 67, 146; (g) Grison, C.; Comoy, C.; Chatenet, D.; Coutrot, P. J.
Organomet. Chem. 2002, 662, 83; (h) Grison, C.; Coutrot, P.; Joliez, S.; Balas, L.
Synthesis 1996, 731.
gated as a new synthetic methodology. A broad variety of nucleo-
philic and electrophilic reagent pairs can be envisioned to prepare
1,1-bis-phosphorus compounds, so that the method has tremen-
dous potential for the preparation of complex compounds from
simple building blocks. The scope of this reaction will be further
explored in the full account. The use of the intermediate anions
for alkylation,1b olefination,1b and other synthetic applications, will
also be the object of forthcoming studies. The intramolecular ver-
sion (the phospha-Dieckmann condensation) will be investigated
in parallel. Overall, the phospha-Claisen reaction (and its Dieck-
mann variant) will provide a simple, halogen-free entry (avoiding
the common P(O)Cl or P(O)CH2Cl intermediates), and powerful tool
for the synthesis of complex organophosphorus compounds of va-
lue as reagents or as intermediates in the synthesis of biologically
active pyrophosphate analogs.
6. Examples: (a) Pudovik, A. N.; Yastrebova, G. E. Russ. Chem. Rev. 1970, 39, 562;
(b) Taylor, S. D.; Mirzaei, F.; Bearne, S. L. Org. Lett. 2006, 8, 4243; (c) Yarkevich,
A. N.; Tsvetkov, E. N. Russ. J. Gen. Chem. 2002, 72, 486; (d) Saady, M.; Lebeau, L.;
Mioskowski, C. Helv. Chim. Acta 1995, 78, 670; (e) Maier, L. Helv. Chim. Acta
1970, 53, 1940.
7. (a) Flohr, A.; Aemissegger, A.; Hilvert, D. J. Med. Chem. 1999, 42, 2663; (b)
ˇ
´
´
Doláková, P.; Dracinsky, M.; Fanfrlík, J.; Holy, A. Eur. J. Org. Chem. 2009, 1082; (c)
Perkin, A. J. Chem. Soc., Perkin Trans.1 1991, 2983.
8. For example, see: (a) Janecki, T.; Kedzia, J.; Wasek, T. Synthesis 2009, 1227; (b)
Kouno, R.; Okauchi, T.; Nakamura, M.; Ichikawa, J.; Minami, T. J. Org. Chem.
1998, 63, 6239; (c) Arimori, S.; Kouno, R.; Okauchi, T.; Minami, T. J. Org. Chem.
2002, 67, 7303; (d) Ageno, T.; Okauchi, T.; Minami, T.; Ishida, M. Org. Biomol.
Chem. 2005, 3, 924; (e) Sadykova, Y. M.; Dalmatova, N. V.; Voronina, Y. K.;
Burilov, A. R.; Pudovik, M. A.; Sinyashin, O. G. Heteroat. Chem. 2012, 23, 340; (f)
Dayde, B.; Benzaria, S.; Pierra, C.; Gosselin, G.; Dominique Surleraux, D.; Volle,
J.-N.; Pirat, J.-L.; Virieux, D. Org. Biomol. Chem. 2012, 10, 3448.
Acknowledgments
We thank the Robert A. Welch Foundation (Grant P-1666) for
the financial support of the bulk of this research (LG). Some mate-
rial is based, in part, upon work supported by the National Science
Foundation under Grant No. 0953368 (FG).
9. Belabassi, Y.; Antczak, M. I.; Tellez, J.; Montchamp, J.-L. Tetrahedron 2008, 64,
9181.
Supplementary data
10. (a) Dingwall, J. G.; Ehrenfreund, J.; Hall, R. G. Tetrahedron 1989, 45, 3787; (b)
Baylis, E. K. Tetrahedron Lett. 1995, 36, 9385; (c) Froestl, W.; Mickel, S. J.; Hall, R.
G.; von Sprecher, G.; Diel, P. J.; Strub, D.; Baumann, P. A.; Brugger, F.; Gentsch,
C.; Jaekel, J.; Olpe, H.-R.; Rihs, G.; Vassout, A.; Waldmeier, P. C.; Bittiger, H. J.
Med. Chem. 1995, 38, 3297; (d) Coudray, L.; Montchamp, J.-L. Eur. J. Org. Chem.
2009, 4646; (e) Fougère, C.; Guénin, E.; Hardouin, J.; Lecouvey, M. Eur. J. Org.
Chem. 2009, 6048; (f) Van Overschelde, M.; Vervecken, E.; Modha, S. G.; Cogen,
S.; Van der Eycken, E.; Van der Eycken, J. Tetrahedron 2009, 65, 6410; (g) Ortial,
S.; Montchamp, J.-L. Org. Lett. 2011, 13, 3134.
Supplementary data (detailed experimental procedures, spectra
data, and NMR spectra) associated with this article can be found, in
11. Luke, G. P.; Shakespeare, W. C. Synth. Commun. 2002, 32, 2951. Compound 1l
was prepared from MePCl2 and MeC(OEt)3.
References and notes
12. We name compound
6 the ‘Bisseret reagent’ based on the original
1. (a) Berger, O.; Gavara, L.; Montchamp, J.-L. Org. Lett. 2012, 14, 3404; (b) Ortial,
S.; Thompson, D. A.; Montchamp, J.-L. J. Org. Chem. 2010, 75, 8166; (c)
Abrunhosa-Thomas, I.; Coudray, L.; Montchamp, J.-L. Tetrahedron 2010, 66,
4434; (d) Antczak, M. I.; Montchamp, J.-L. Tetrahedron Lett. 2008, 49, 5909; (e)
Gouault-Bironneau, S.; Deprèle, S.; Sutor, A.; Montchamp, J.-L. Org. Lett. 2005, 7,
5909.
2. (a) Teulade, M.-P.; Savignac, P.; Aboujaoude, E. E.; Lietge, S.; Collignon, N. J.
Organomet. Chem. 1986, 304, 283; (b) Teulade, M.-P.; Savignac, P.; Aboujaoude,
E. E.; Collignon, N. J. Organomet. Chem. 1986, 312, 283.
contribution: (a) Bisseret, P.; Eustache, J. Tetrahedron Lett. 2001, 42, 8451;
Several applications have appeared: (b) Lecercié, D.; Sawicki, M.; Taran, F. Org.
Lett. 2006, 8, 4283; (c) Thielges, S.; Bisseret, P.; Eustache, J. Org. Lett. 2005, 7,
681; (d) Bisseret, P.; Boiteau, J.-G.; Eustache, J. Tetrahedron Lett. 2003, 44, 2351.
13. Robinson, C. N.; Lewis, R. C. J. Heterocycl. Chem. 1973, 395.
14. (a) Bracegirdle, S.; Anderson, E. A. Chem. Soc. Rev. 2010, 39, 4114; (b) Gauthier,
D. R., Jr.; Zandi, K. S.; Shea, K. J. Tetrahedron 1998, 54, 2289; (c) Bols, M.;
Skrydstrup, T. Chem. Rev. 1995, 95, 1253.